<DOC>
	<DOCNO>NCT00293696</DOCNO>
	<brief_summary>To evaluate anti-androgen ( bicalutamide ) induce biological molecular change prostate comparison chemical castration induce ( goserelin ) one</brief_summary>
	<brief_title>Casodex/Zoladex Biomarkers Localised Prostate Cancer</brief_title>
	<detailed_description />
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<mesh_term>Goserelin</mesh_term>
	<mesh_term>Bicalutamide</mesh_term>
	<criteria>1 . Histologically confirm localised prostate biopsy specimen contain sufficient tumour evaluation cell proliferation apoptosis marker 2 . Patients scheduled radical prostatectomy curative intent</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>May 2007</verification_date>
	<keyword>biomarker study</keyword>
	<keyword>Patients clinically localised prostate cancer</keyword>
</DOC>